Cited by
Cited by
AML-1 is required for megakaryocytic maturation and lymphocytic differentiation, but not for maintenance of hematopoietic stem cells in adult hematopoiesis
M Ichikawa, T Asai, T Saito, G Yamamoto, S Seo, I Yamazaki, T Yamagata, ...
Nature medicine 10 (3), 299-304, 2004
Notch2 is preferentially expressed in mature B cells and indispensable for marginal zone B lineage development
T Saito, S Chiba, M Ichikawa, A Kunisato, T Asai, K Shimizu, T Yamaguchi, ...
Immunity 18 (5), 675-685, 2003
The leukemogenicity of AML1-ETO is dependent on site-specific lysine acetylation
L Wang, A Gural, XJ Sun, X Zhao, F Perna, G Huang, MA Hatlen, L Vu, ...
Science 333 (6043), 765-769, 2011
Acetylation of GATA‐3 affects T‐cell survival and homing to secondary lymphoid organs
T Yamagata, K Mitani, H Oda, T Suzuki, H Honda, T Asai, K Maki, ...
The EMBO Journal, 2000
AML1 is functionally regulated through p300-mediated acetylation on specific lysine residues
Y Yamaguchi, M Kurokawa, Y Imai, K Izutsu, T Asai, M Ichikawa, ...
Journal of Biological Chemistry 279 (15), 15630-15638, 2004
AML1/Runx1 rescues Notch1-null mutation-induced deficiency of para-aortic splanchnopleural hematopoiesis
M Nakagawa, M Ichikawa, K Kumano, S Goyama, M Kawazu, T Asai, ...
Blood 108 (10), 3329-3334, 2006
AML1/Runx1 negatively regulates quiescent hematopoietic stem cells in adult hematopoiesis
M Ichikawa, S Goyama, T Asai, M Kawazu, M Nakagawa, M Takeshita, ...
The Journal of Immunology 180 (7), 4402-4408, 2008
The p53 tumor suppressor protein regulates hematopoietic stem cell fate
T Asai, Y Liu, N Bae, SD Nimer
Journal of cellular physiology 226 (9), 2215-2221, 2011
Long‐term ultra‐low‐dose acyclovir against varicella‐zoster virus reactivation after allogeneic hematopoietic stem cell transplantation
Y Asano‐Mori, Y Kanda, K Oshima, S Kako, A Shinohara, H Nakasone, ...
American journal of hematology 83 (6), 472-476, 2008
Runx1/AML-1 ranks as a master regulator of adult hematopoiesis
M Ichikawa, T Asai, S Chiba, M Kurokawa, S Ogawa
Cell cycle 3 (6), 720-722, 2004
Host-residual invariant NK T cells attenuate graft-versus-host immunity
K Haraguchi, T Takahashi, A Matsumoto, T Asai, Y Kanda, M Kurokawa, ...
The Journal of Immunology 175 (2), 1320-1328, 2005
False-positive Aspergillus galactomannan antigenaemia after haematopoietic stem cell transplantation
Y Asano-Mori, Y Kanda, K Oshima, S Kako, A Shinohara, H Nakasone, ...
Journal of antimicrobial chemotherapy 61 (2), 411-416, 2008
TT virus in bone marrow transplant recipients
Y Kanda, Y Tanaka, M Kami, T Saito, T Asai, K Izutsu, K Yuji, S Ogawa, ...
Blood, The Journal of the American Society of Hematology 93 (8), 2485-2490, 1999
The p53 tumor suppressor protein is a critical regulator of hematopoietic stem cell behavior
Y Liu, SE Elf, T Asai, Y Miyata, Y Liu, G Sashida, G Huang, ...
Cell cycle 8 (19), 3120-3124, 2009
Crk-associated substrate lymphocyte type is required for lymphocyte trafficking and marginal zone B cell maintenance
S Seo, T Asai, T Saito, T Suzuki, Y Morishita, T Nakamoto, M Ichikawa, ...
The Journal of Immunology 175 (6), 3492-3501, 2005
Necdin, a p53 target gene, regulates the quiescence and response to genotoxic stress of hematopoietic stem/progenitor cells
T Asai, Y Liu, S Di Giandomenico, N Bae, D Ndiaye-Lobry, A Deblasio, ...
Blood, The Journal of the American Society of Hematology 120 (8), 1601-1612, 2012
The Checkpoint Kinase Inhibitor AZD7762 Potentiates Chemotherapy-Induced Apoptosis of p53-Mutated Multiple Myeloma Cells
HJ Landau, SC McNeely, JS Nair, RL Comenzo, T Asai, H Friedman, ...
Molecular cancer therapeutics 11 (8), 1781-1788, 2012
The transcriptionally active form of AML1 is required for hematopoietic rescue of the AML1-deficient embryonic para-aortic splanchnopleural (P-Sp) region
S Goyama, Y Yamaguchi, Y Imai, M Kawazu, M Nakagawa, T Asai, ...
Blood 104 (12), 3558-3564, 2004
Increased soluble Fas-ligand in sera of bone marrow transplant recipients with acute graft-versus-host disease
Y Kanda, Y Tanaka, K Shirakawa, T Yatomi, N Nakamura, M Kami, T Saito, ...
Bone marrow transplantation 22 (8), 751-754, 1998
CARM1 is essential for myeloid leukemogenesis but dispensable for normal hematopoiesis
SM Greenblatt, N Man, PJ Hamard, T Asai, D Karl, C Martinez, D Bilbao, ...
Cancer cell 33 (6), 1111-1127. e5, 2018
The system can't perform the operation now. Try again later.
Articles 1–20